Crossmark

Hybrid histone deacetylase-kinase inhibitor potentiates venetoclax-induced cell death in chronic lymphocytic leukemia

Crossref DOI link: https://doi.org/10.1016/j.htct.2025.103757

Published Print: 2025-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Garnique, Anali Del Milagro Bernabe

Carlos, Jorge Antonio Elias Godoy https://orcid.org/0000-0002-2833-4665
Parducci, Natalia Sudan

Tavares, Mauricio Temotheo https://orcid.org/0000-0002-4400-7787
Waitman, Karoline de Barros https://orcid.org/0000-0003-2382-534X
Lima, Keli

Costa-Lotufo, Leticia Veras

Parise-Filho, Roberto https://orcid.org/0000-0002-9311-7245
Machado-Neto, João Agostinho https://orcid.org/0000-0002-2937-8109
Funding

Funding for this research was provided by:

Coordination of Higher Education Personnel Improvement

State of Sao Paulo Research Foundation (2021/11606-3, 2021/08260-8, 2024/07723-2, 2023/12246-6)

National Council for Scientific and Technological Development
License Information

Text and Data Mining valid from 2025-04-01

Text and Data Mining valid from 2025-04-01

Version of Record valid from 2025-03-15
More Information

This article is maintained by: Elsevier

Article Title: Hybrid histone deacetylase-kinase inhibitor potentiates venetoclax-induced cell death in chronic lymphocytic leukemia

Journal Title: Hematology, Transfusion and Cell Therapy

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.htct.2025.103757

Content Type: simple-article

Copyright: © 2025 Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier España, S.L.U.